Neuraxis, INC

Now, Therefore, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Plan is amended as follows:

Section 5.1. Stock Grant and Award Limits. The Committee may from time to time grant Awards to one or more Employees, Directors and/or Consultants determined by it to be eligible for participation in the Plan in accordance with the provisions of ARTICLE VI. Subject to ARTICLE XIV, the aggregate number of shares of Common Stock (including shares of Common Stock underlying Options designated as Incentive Stock Options) that may be issued under the Plan shall not exceed three million four hundred thousand (3,400,000) shares of Common Stock, plus an annual increase on the first day of each calendar year beginning January 1, 2027 and ending on and including January 1, 2033 equal to the lesser of (A) five percent (5%) of the Common Shares outstanding on the final day of the immediately preceding calendar year, and (B) such smaller number of Common Shares as determined by the Board or the Compensation Committee. The Common Stock shall be deemed to have been issued under the Plan solely to the extent actually issued and delivered pursuant to an Award. To the extent that an Award lapses, expires, is canceled, is terminated unexercised or ceases to be exercisable for any reason, or the rights of its Holder terminate, any Common Stock subject to such Award shall again be available for the grant of a new Award.

[Remainder of Page Left Blank Intentionally.]

In Witness Whereof, the Company's undersigned duly authorized officer has signed this Third Amendment to Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan.

NeurAxis, Inc.

By:

Name: Brian Carrico Title: Chief Executive OfficerDate:

Signature PagetoThird Amendment